Daily Archives: May 15, 2012

Warning and NOV Letter Summary – 1st Quarter 2012

Another quarter has zoomed by. ¬†And with it, FDA’s Office of Prescription Drug Promotion (OPDP), formerly known as the Division of Drug Marketing, Advertising and Communications (DDMAC), has issued a stream of regulatory action letters known as Notice of Violation … Continue reading

Posted in Warning Letters | Comments Off